This 30-minute educational webinar that will be held on Jun 17, 2025 02:00 PM is designed for clinicians and other providers seeking to optimize biomarker testing strategies in non-small cell lung cancer (NSCLC). The session provides a comprehensive overview of when and how to utilize tissue and liquid biopsy specimens across the NSCLC care continuum.

Educational objectives for this webinar include:

• Understanding when to use tissue, liquid, or both biopsy types to optimize biomarker detection
• Learning various factors that can influence circulating tumor DNA (ctDNA) testing results
• Recognizing the importance of having biomarker results available before initiating first-line therapy to guide targeted treatment decisions
• Gaining clarity on payer policies, including Medicare and commercial coverage, and how they vary by specimen type, disease stage, and test timing